Nasdaq nmra.

Neumora Therapeutics, Inc. Common Stock (NMRA) Option Chain | Nasdaq. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for ...The Watertown, MA-based Neumora Therapeutics ( NASDAQ: NMRA ), a Phase 3 biotech developing therapies for brain diseases has priced its initial public offering of 14.71 million shares of its ...Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA Get Free Report) traded up 4.6% on Friday . The stock traded as high as $11.21 and last traded at $11.09. 32,521 shares were traded during... Share to Feed. Insider Buying: Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Purchases 30,192 Shares of Stock Ticker Report • …Research Neumora Therapeutics' (Nasdaq:NMRA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...Corcept Therapeutics Stock (NASDAQ: CORT) stock price, news, charts, stock research, profile.

NVDA. NVIDIA Corporation Common Stock. $439.00 -16.81 -3.69%. Find the latest historical data for Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com.

Neumora Therapeutics, Inc.(NasdaqGS:NMRA) added to NASDAQ Composite Index Sep. 18: CI Neumora Therapeutics, Inc. has completed an IPO in the amount of $250.07 million. ... (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist in Phase 3 development as a potential monotherapy treatment for …

Sep 21, 2023 · Shares of Neumora Therapeutics (NMRA 0.41%) were down more than 32% for the week as of Thursday's market close, according to data provided by S&P Global Market Intelligence. WATERTOWN, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ...Aug 28, 2023 · AzmanJaka. A Quick Take On Neumora Therapeutics. Neumora Therapeutics, Inc. (NASDAQ:NMRA) as filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration ... Neumora Therapeutics, Inc. (NASDAQ:NMRA) as filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement.The latest price target for . Neumora Therapeutics (NASDAQ: NMRA) was reported by JP Morgan on November 8, 2023.The analyst firm set a price target for $20.00 expecting NMRA to rise to within 12 ...

Sep 14, 2023 · 1 Trading Held Add to Watchlist Add to Portfolio Quotes Summary Sep 14, 2023 9:14 am 0 Previous Close $17.00 Key Data Bid Price and Ask Price The bid & ask refers to the price that an investor is...

Neumora Therapeutics, Inc. (NASDAQ: NMRA) is a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. Neumora is redefining neuroscience research and development with a data-driven precision neuroscience platform to cut through brain disease heterogeneity ...

WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience …Nov 27, 2023 · 1.55. EBIT. -130.9. -237.31. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Neumora Therapeutics, Inc. (NMRA). See many years of revenue, expenses and ... Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder WATERTOWN, Mass.--(BUSINESS WIRE)--Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the planned initiation of the …Dec 2, 2023 · Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) – Investment analysts at William Blair decreased their FY2023 earnings estimates for Neumora Therapeutics in a report issued on Monday, November 27th. William Blair analyst M. Minter now forecasts that the company will post earnings of ($4.25) per share for the year, down from their previous estimate of […] Veja a previsão de preço das ações da Neumora Therapeutics, Inc. para 1 ano, feita pelos analistas e compare-a com as mudanças de preço ao longo do tempo para desenvolver …Neumora Therapeutics, Inc. (NASDAQ: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the pricing of its initial public offering of ...

Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ...Find the latest news headlines from Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.Sep 28, 2023 · VinFast Auto Ltd. (NASDAQ:VFS) gained 13.6% to $12.73 following a report suggesting the company is planning to set up a manufacturing plant in India. Neumora Therapeutics, Inc. (NASDAQ:NMRA ... Member FINRA / SIPC / NYSE / NASDAQ / CBOE EDGX. Webull offers NMRA Ent Holdg (NMRA) historical stock prices, in-depth market analysis, NASDAQ: NMRA real-time stock quote data, in-depth charts, free NMRA options chain data, and a fully built financial calendar to help you invest smart. Buy NMRA stock at Webull. Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc bought 3,357 shares of the company’s stock in a transaction on Tuesday, November 14th.

Veja a previsão de preço das ações da Neumora Therapeutics, Inc. para 1 ano, feita pelos analistas e compare-a com as mudanças de preço ao longo do tempo para desenvolver …

Shares of Neumora Therapeutics (NASDAQ: NMRA) were down more than 32% for the week as of Thursday's market close, according to data provided by S&P Global Market Intelligence.Neumora Therapeutics, Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics, Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Current. -$0.75. 1 Month Ago. -$0.75. 3 Months Ago. N/A. Neumora Therapeutics Inc. analyst estimates, including NMRA earnings per share estimates and analyst recommendations.Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.CGC. Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Find the latest SEC Filings data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.On October 10, 2023, Geoff Meacham, an analyst at Bank of America Securities, commenced coverage on Neumora Therapeutics (NASDAQ:NMRA) by Analyst Coverage and Price Targets for Neumora Therapeutics - Best StocksNeumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Nov 27, 2023 · NMRA-266 is an investigational positive allosteric modulator of the M4 muscarinic receptor subtype, a clinically validated target for the treatment of schizophrenia. Neumora exclusively licensed ...

6 hari yang lalu ... (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced that the Company will ...

Neumora Therapeutics (NASDAQ: NMRA), a biotech company focused on developing treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s, went public on September 15th with ...

... (NASDAQ: NMRA), and Syllable Life Sciences (acquired by Neumora). Portfolio. Atalanta Therapeutics. Atalanta Therapeutics is a biotechnology company pioneering ...Neumora Therapeutics, Inc. (NASDAQ: NMRA) is a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. Neumora is redefining neuroscience research and development with a data-driven precision neuroscience platform to cut through brain disease heterogeneity ...Sep 26, 2023 · Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Oct 10, 2023 · Shares of Neumora Therapeutics Inc (NASDAQ:NMRA) were trading lower on Tuesday, a month after the company announced its IPO on the NASDAQ exchange.. RBC Capital Markets On Neumora Therapeutics ... View real-time NMRA stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...Member FINRA / SIPC / NYSE / NASDAQ / CBOE EDGX. Webull offers NMRA Ent Holdg (NMRA) historical stock prices, in-depth market analysis, NASDAQ: NMRA real-time stock quote data, in-depth charts, free NMRA options chain data, and a fully built financial calendar to help you invest smart. Buy NMRA stock at Webull.Nov 1, 2023 · Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ... See the latest Neumora Therapeutics Inc stock price (NMRA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Neumora Therapeutics, Inc. Common Stock (NMRA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Sep 12, 2023 · A Quick Take On Neumora Therapeutics. Neumora Therapeutics, Inc. ( NASDAQ: NMRA) has filed proposed terms to raise $250 million from the sale of its common stock in an IPO, according to an amended ... A high-level overview of Neumora Therapeutics, Inc. (NMRA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …

--Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the appointment of Robert Lenz, M.D., Ph.D., as executive vice ...Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ...NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor, a clinically validated target for the treatment of schizophrenia WATERTOWN, Mass., Nov. 27, 2023 (GLOBE ...Sep 15, 2023 · The Watertown, MA-based Neumora Therapeutics ( NASDAQ: NMRA ), a Phase 3 biotech developing therapies for brain diseases has priced its initial public offering of 14.71 million shares of its ... Instagram:https://instagram. 1964 jfk half dollar coin valueheatmap stock marketfarfetch websitenysearca uup NMRA | Complete Neumora Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience … alllotgle 63 amg s Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical ...WATERTOWN, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug ... dividend for gm CGC. Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Find the latest SEC Filings data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.EHang Holdings Ltd ADR (NASDAQ:EH) showed a performance of -24.51% in past 30-days. Number of shares sold short was 8.79 million shares which calculate 11.8 days to cover the short interests. Wall Street analysts have assigned a consensus price target of $222.79 to the stock, which implies a rise of 93.55% to its current value.Oct 18, 2023 · Christoph Burgstedt/iStock via Getty Images. Company logo. I started a long position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) last week with a 4.2% portfolio allocation.This recent central ...